As of 2025-02-14, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (210.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.65 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -1292.7%.
The range of the Relative Valuation is (194.51) - (259.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 18.9x - 42.4x | 29.2x |
Forward P/E multiples | 29.2x - 38.9x | 34.0x |
Fair Price | (194.51) - (259.08) | (210.52) |
Upside | -1202.0% - -1567.9% | -1292.7% |
Date | P/E |
2025-02-07 | -2.67 |
2025-02-06 | -2.67 |
2025-02-05 | -2.70 |
2025-02-04 | -2.68 |
2025-02-03 | -2.60 |
2025-01-31 | -2.56 |
2025-01-30 | -2.60 |
2025-01-29 | -2.54 |
2025-01-28 | -2.51 |
2025-01-27 | -2.51 |
2025-01-24 | -2.45 |
2025-01-23 | -2.46 |
2025-01-22 | -2.44 |
2025-01-21 | -2.48 |
2025-01-17 | -2.41 |
2025-01-16 | -2.43 |
2025-01-15 | -2.41 |
2025-01-14 | -2.34 |
2025-01-13 | -2.39 |
2025-01-10 | -2.34 |
2025-01-08 | -2.39 |
2025-01-07 | -2.36 |
2025-01-06 | -2.39 |
2025-01-03 | -2.43 |
2025-01-02 | -2.44 |
2024-12-31 | -2.47 |
2024-12-30 | -2.44 |
2024-12-27 | -2.44 |
2024-12-26 | -2.50 |
2024-12-24 | -2.45 |
2024-12-23 | -2.44 |
2024-12-20 | -2.45 |
2024-12-19 | -2.45 |
2024-12-18 | -2.41 |
2024-12-17 | -2.50 |
2024-12-16 | -2.54 |
2024-12-13 | -2.58 |
2024-12-12 | -2.60 |
2024-12-11 | -2.68 |
2024-12-10 | -2.68 |
2024-12-09 | -2.59 |
2024-12-06 | -2.62 |
2024-12-05 | -2.63 |
2024-12-04 | -2.64 |
2024-12-03 | -2.61 |
2024-12-02 | -2.64 |
2024-11-29 | -2.66 |
2024-11-27 | -2.66 |
2024-11-26 | -2.66 |
2024-11-25 | -2.58 |